Lower serum lipid levels are related to respiratory impairment in patients with ALS
- 17 November 2009
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 73 (20), 1681-1685
- https://doi.org/10.1212/wnl.0b013e3181c1df1e
Abstract
Background: Recently hyperlipidemia was reported to be related to a significantly better outcome in amyotrophic lateral sclerosis (ALS). To investigate this, we evaluated the status of blood lipids in a large Italian series of patients with ALS, and assessed the effect of hyperlipidemia on patients’ survival. Methods: The study population included 658 patients with ALS consecutively observed in 2 Italian ALS centers between 2000 and 2006. They were compared to a series of 658 healthy subjects, matched by age and gender. Results: The mean levels of total cholesterol, triglycerides, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and the LDL/HDL ratio were similar in patients with ALS and controls. Total cholesterol, HDL, triglyceride, and LDL/HDL ratio levels showed a significant decrease in patients with forced vital capacity 2.99 or patients in the first quartile of LDL/HDL ratio (≤1.67) vs those in the fourth quartile (>2.79). No dose-response was found for LDL/HDL ratio subdividing patients into 5 quintiles. Conclusion: Our findings do not support the observation that patients with amyotrophic lateral sclerosis have hyperlipidemia or that hyperlipidemia in this population is related to longer survival. However, some evidence emerged that respiratory impairment, but not a worse clinical status or a lower body mass index, is related to a decrease in blood lipids and LDL/HDL ratio.Keywords
This publication has 14 references indexed in Scilit:
- Loci influencing lipid levels and coronary heart disease risk in 16 European population cohortsNature Genetics, 2008
- Influence of statins treatment on survival in patients with amyotrophic lateral sclerosisJournal of the Neurological Sciences, 2008
- An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting systemPharmacoepidemiology and Drug Safety, 2008
- Dyslipidemia is a protective factor in amyotrophic lateral sclerosisNeurology, 2008
- Are statin medications safe in patients with ALS?Amyotrophic Lateral Sclerosis, 2008
- Prognostic factors in ALS: A critical reviewAmyotrophic Lateral Sclerosis, 2008
- Statins, Neuromuscular Degenerative Disease and an Amyotrophic Lateral Sclerosis-Like SyndromeDrug Safety, 2007
- Prevalence of the metabolic syndrome among Italian adults according to ATP III definitionNutrition, Metabolism and Cardiovascular Diseases, 2005
- The Impact of Nutritional Status on the Outcome of Lung Volume Reduction SurgeryChest, 1999
- Effects of Mediterranean Diet on Lipid Levels and Cardiovascular Risk in Renal Transplant RecipientsNephron, 1999